bharat biotech

Only marginal difference in purchase price of Covishield and Covaxin for Centre: MoS Health

The Centre is purchasing Covishield and Covaxin doses at the rate of Rs 205 and Rs 215 per dose, respectively,…

3 years ago

Following termination of vaccination agreement with Bharat Biotech, Brazil halts clinical studies of Covaxin

Brazil has suspended the clinical studies of Bharat Biotech's Covid-19 vaccine Covaxin after termination of the company's agreement with its…

3 years ago

Bharat Biotech terminates MoU with Brazilian partners after graft allegations

Bharat Biotech on Friday, 23 July, announced the termination of its memorandum of understanding (MOU) with Precisa Medicamentos and Envixia…

3 years ago

Covaxin offers significant protection against Beta, Delta variants: ICMR study

Bharat Biotech and Indian Council of Medical Research’s (ICMR) Covid vaccine Covaxin offers significant protection against both Beta and Delta…

3 years ago

Govt clarifies claims of production of Covaxin via calf serum

Does Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, contain serum of the newborn…

3 years ago

Bharat Biotech shares full research data of COVAXIN

Bharat Biotech has shared full data of all research studies of COVAXIN, its COVID-19 vaccine. A company statement said, “The…

3 years ago

USFDA denies Bharat Bhiotech’s partner emergency approval for Covaxin

In a recent development, the US Food and Drug Administration there has "recommended" Ocugen Inc, the US partner of the…

3 years ago

Bharat Biotech to conduct Phase IV trial soon, Phase III trial data to be published in July

Amid the Twitter war between Bharat Biotech's Raches Ella and Kolkata researcher Dr Aswadhesh Kumar Singh over Covaxin versus Covishield, Bharat…

3 years ago

Ocugen, Bharat Biotech sign agreement for commercialisation rights to COVAXIN in Canada

Ocugen and Bharat Biotech have entered into an amendment to their Co-development, Supply, and Commercialization Agreement to expand Ocugen’s exclusive…

3 years ago

Haffkine Biopharma to produce 22.8 crore doses per annum of Covaxin

Maharashtra state-owned Haffkine Biopharma on June 2 said it plans to produce 22.8 crore (228 million) doses of Covaxin in…

3 years ago